We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

August 15, 2018

FemTech - Empowering Women's Health and Wellness

Commentary
Hanna Phelan
&

Gender parity is a topic that will make some of you wince - but bear with us. Despite women holding a core role in healthcare as consumers, caregivers and health professionals there has been an obvious disparity to date when it comes to representation in healthcare leadership positions. Digital Health startups, and the industry more broadly, have been shaking-up the lackluster trend of female underrepresentation in healthcare and technology sectors with a reported 25% of digital health CEOs being female (hopefully we’ll get to a point where we can disregard these types of metrics). This movement of mounting female representation in digital health Executives is reflected in the rising tide of FemTech - unsurprisingly increased female representation in the sector leads to increased understanding of women's health needs and a de-stigmatization of areas previously left in the shadows. Enter FemTech.

So, what exactly is FemTech? FemTech is a rapidly growing area of digital health targeted at women’s health and wellness - from rapid diagnostics and to remote monitoring, and beyond. It is also a market that through it’s broad spectrum of offerings, including reproductive and maternal tech interventions, is predicted to hold a value of $50 Billion by 2025. Sound growth of this sector and increased dialogue and investment in women's health does not promise to only improve the QoL of women, but as a substantial body of literature has highlighted societies that prioritize women’s health will likely have better population health overall and promise to deliver substantial economic return.

The time has come where women’s health is no longer seen as a niche sector or secondary consideration - with 50% of the global population as target customers this seems like a wise shift. Read on from an insight into some of the most promising Reproductive and Maternal focused consumer facing FemTech solutions offering to empower women from conception to pregnancy.

Fertility and Contraceptive Support Applications

Direct to consumer health and wellness solutions, and FemTech specifically, have benefitted from a favorable regulatory landscape in the past few years. This has set a great precedent for fertility and contraception solutions created for female consumers looking to achieve heightened ability to self-manage a core aspect of their health.

Natural Cycles, a solution which allows women to take their temperature with a connected thermometer which then feeds the reading through an algorithm to deduce what point of their cycle the user is at, was the first of it’s kind to achieve CE approval as a Class-Two medical device. Clinical studies have shown that Natural Cycles is 93% effective for contraception with a typical Pearl Index of 7.0. - meaning that during one year, 7 women out of 100 get pregnant due to a variety of reasons, including having intercourse without protection on days flagged by the app as high fertility days. What is particularly interesting about Natural Cycles is their integration of sexual and reproductive health education, helping to educate and sustain women's self-management and empowerment beyond the app.

Ava Health iPhone App
Ava Health iPhone App

Like Natural Cycles, Ava Health have integrated a hardware element, however Ava have opted for a wrist based wearable for a more passive temperature insight. The FDA approved Ava as a Class-One medical device in 2016 in another big win for FemTech regulation and validation.

Leading solutions in the contraceptive and fertility monitoring space recognise the value of long term interventions that will expand the knowledge of women around their reproductive health and give them actionable insights seen in the educational features and advanced analytics of Clue, Natural Cycles and Ava. Another valuable point of consideration is integrating more tracking of general health and wellness biometrics and measures in order to gain a holistic insight and connecting to further services such as telemedicine consultations and mental health and meditation tools.

It’s not only startup digital health companies that have ventured into the promising and much needed fertility and contraceptive space. In March 2018 FitBit launched their own period and ovulation tracking platform that is intended for launch later this year. FitBit will allow consumers of this service to join a community of women where they can discuss and learn more about periods, birth control,conception, pregnancy, and perimenopause and menopause.

Beyond fertility tracking applications and sensors there is a new wave of telemedicine and pharmacy services offering a streamlined way for women to access their contraceptive pill prescriptions such as Nurx who are targeted specifically at providing affordable and accessible contraceptives. Users of Nurx simply choose their brand of choice, answer a questionnaire which is then reviewed by a clinician and finally the pill will be delivered straight to the consumer.

Pregnancy Support Solutions

Pregnant woman have always been strategic targets for brands - so it’s a little surprising that it has taken so long for solutions that support and guide women throughout their 9 months to make their way to consumers. Thankfully the direct to consumer market is now awash with solutions looking to do just that for expecting mothers and supporting traditional OB/GYN services and data driven understanding of physiological reactions during pregnancy.

This is clearly a delicate point in the care pathway for a digital health intervention which alludes to maintain high expectations when it comes to clinical validation. Bloomlife offers a lightweight adhesive monitor and mobile app monitors real-time uterine activity for contraction frequency, duration, patterns and trends of contractions to take the guesswork out of when to seek medical attention from a healthcare provider - particularly useful in the third trimester. In late 2017 Bloomlife received grants totaling $2.3 million in order to carry out a longitudinal study validating their offering. Fertility tracking application Ava also just launched a clinical trial of their wearable in detecting the onset of infection during a wearer’s pregnancy.

Bloomlife monitor and mobile app
Bloomlife monitor and mobile app

Lucina Health is another solution that aims to support safe pregnancies through their data driven system for the early warning of preterm birth. Using advanced analytics the Lucina platform analyses risk factors and metrics collected during antenatal check ups by obstetricians and foreshadows challenges that may lie around the corner. This clinician facing platform connects to a consumer facing app which facilitates communication between HCP and patient.

So, what's next for FemTech?

We have entered into an era where crucially important attention and investment is being allocated to women’s health - and as an industry, digital health is making great strides enabling consumers to take charge of their own health and wellness. this is a great stride particularly considering that in some parts of the US and Europe 30 years ago breast cancer would have been seen as a taboo topic - the growth of FemTech is slowing changing this whole dynamic.

FemTech is undoubtedly set to excel from this nascent stage to great heights of maturity and potential. In order to get there as an industry we need to keep some key points in mind such as communicating these opportunities to women, validating and specializing solution offerings and integrating pregnancy focused solutions with HCPs to provide a truly supportive and insightful loop. For FemTech the sky's the limit for increasing, access, understanding and reducing unnecessary costs. Like our hope for 'digital health' to simply become 'health' as it scales and matures, we hope that the continued realisation of the value of investing in women's health will not require it's own name in the near future - for now it is highlighting an essential attention point in healthcare globally.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

Ready to read more? HealthXL members can access the full peak of the report on the HealthXL Community Hub.

Not yet a member of HealthXL? Download your 11 page snapshot of the report.

Download your 11 page snapshot

Connect with peers and share insights

Don't miss out on the discussion of the latest insights and reports on digital health. Meet with peers and take a deep dive for 75 minutes. Unlike at webinars, you can freely exchange experiences and insights to solve challenges and design the future of DTx.

Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

Sprint: Prescription DTx - Commercialization Models & Adoption

21st September @ 10:45AM EDT

Join this series of 2 meetings to discuss with other senior leaders Commercialization Models & Adoption in Prescription DTx. Limited spaces available so apply now to secure your place in the conversation.

Featuring
Lee Shapiro
Lee Shapiro
Managing Partner, 7wire Ventures
Michael Pace
Michael Pace
Founder and President at PalmHealth.co
Featuring
Lee Shapiro
Lee Shapiro
Managing Partner, 7wire Ventures
Michael Pace
Michael Pace
Founder and President at PalmHealth.co
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

DTx - Medtech partnerships

23rd September @ 10:45AM EDT

Join us in this informal conversation with senior leaders how DTx companies should think about Medtech as the appropriate partner and vice versa. Apply now to connect with peers and network with new people.

Featuring
Lisa Suennen
Lisa Suennen
Group Leader, Manatt Ventures
Sean Cheng
Sean Cheng
VC Investor, Philips Ventures
Featuring
Lisa Suennen
Lisa Suennen
Group Leader, Manatt Ventures
Sean Cheng
Sean Cheng
VC Investor, Philips Ventures
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

DTx in Mental Health: Scaling access to care - Fireside chat with Big Health Co-founder & CEO Peter Hames

23rd September @ 10:00AM EDT

Do you want to learn from one of the top DTx companies in mental health? Join us in this exclusive fireside chat with Peter Hames, co-Founder and CEO at Big Health, where we will talk about the early days of DTx in mental health, Big Health’s differentiated commercialization models, industry leading clinical evidence and the significant opportunity to address the mental health crisis by expanding access to mental health care.

Featuring
Peter Hames
Peter Hames
Co-Founder & CEO of Big Health
Martin Kelly
Martin Kelly
Co-founder & CEO, HealthXL
Featuring
Peter Hames
Peter Hames
Co-Founder & CEO of Big Health
Martin Kelly
Martin Kelly
Co-founder & CEO, HealthXL
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

Sprint: DTx for Mental Health

28th September @ 10:45AM EDT

This series of 2 meetings to discuss in detail with other senior leaders the current state of DTx in mental health, what indications are best suited to such interventions, and commercial opportunities that they present.  Perfect opportunity to listen, engage and enjoy.

Featuring
Krys Zaluski
Krys Zaluski
Director Of Business Development - Digital Health at Sunovion Pharmaceuticals
Francesca Wuttke
Francesca Wuttke
Chief Digital Officer, Almirall
Featuring
Krys Zaluski
Krys Zaluski
Director Of Business Development - Digital Health at Sunovion Pharmaceuticals
Francesca Wuttke
Francesca Wuttke
Chief Digital Officer, Almirall

Are you a HealthXL Member? See the Full Report Here

Non-HealthXL Member? You can purchase the report HERE

HealthXL Digital Health Meetings

Want to join the discussion now?

Join our Digital Health Meetings and take a deep dive for 75 minutes into topics like digital therapeutics, patient support, telehealth, clinical trials, dermatology and many more. These Meetings are not regular webinars: No audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And with a free account on our Community Hub, you stay connected and up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

Sprint: Prescription DTx - Commercialization Models & Adoption

21st September @ 10:45AM EDT

Join this series of 2 meetings to discuss with other senior leaders Commercialization Models & Adoption in Prescription DTx. Limited spaces available so apply now to secure your place in the conversation.

Featuring
Lee Shapiro
Lee Shapiro
Managing Partner, 7wire Ventures
Michael Pace
Michael Pace
Founder and President at PalmHealth.co
Featuring
Lee Shapiro
Lee Shapiro
Managing Partner, 7wire Ventures
Michael Pace
Michael Pace
Founder and President at PalmHealth.co
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery

Commercialization models for Virtual Care in Cardiometabolic Diseases

21st September @ 9:45AM EDT

Join us as we discuss commercialization models for Virtual Care in Cardiometabolic Diseases. Our 75 minute sessions are highly interactive and give attendees the opportunity to hear from senior leaders in the space and also share their own thoughts on the topic

Featuring
Shahram Sharif
Shahram Sharif
Board Director, LindaCare
Abhishek Shah
Abhishek Shah
CEO, Wellthy Therapeutics
Featuring
Shahram Sharif
Shahram Sharif
Board Director, LindaCare
Abhishek Shah
Abhishek Shah
CEO, Wellthy Therapeutics
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

DTx - Medtech partnerships

23rd September @ 10:45AM EDT

Join us in this informal conversation with senior leaders how DTx companies should think about Medtech as the appropriate partner and vice versa. Apply now to connect with peers and network with new people.

Featuring
Lisa Suennen
Lisa Suennen
Group Leader, Manatt Ventures
Sean Cheng
Sean Cheng
VC Investor, Philips Ventures
Featuring
Lisa Suennen
Lisa Suennen
Group Leader, Manatt Ventures
Sean Cheng
Sean Cheng
VC Investor, Philips Ventures
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

DTx in Mental Health: Scaling access to care - Fireside chat with Big Health Co-founder & CEO Peter Hames

23rd September @ 10:00AM EDT

Do you want to learn from one of the top DTx companies in mental health? Join us in this exclusive fireside chat with Peter Hames, co-Founder and CEO at Big Health, where we will talk about the early days of DTx in mental health, Big Health’s differentiated commercialization models, industry leading clinical evidence and the significant opportunity to address the mental health crisis by expanding access to mental health care.

Featuring
Peter Hames
Peter Hames
Co-Founder & CEO of Big Health
Martin Kelly
Martin Kelly
Co-founder & CEO, HealthXL
Featuring
Peter Hames
Peter Hames
Co-Founder & CEO of Big Health
Martin Kelly
Martin Kelly
Co-founder & CEO, HealthXL

What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.